{"status": "Ok", "redirect_url": "https://www.investor.jnj.com/investor-news/news-details/2026/Johnson--Johnson-late-breaking-results-show-nipocalimab-significantly-reduced-systemic-lupus-erythematosus-SLE-disease-activity-in-a-Phase-2-study/default.aspx", "message": "News view counter 776664 successfully enlarged"}